Combined oropharyngeal/nares and nasopharyngeal swab sampling remain effective for molecular detection of SARS-CoV-2 Omicron variant
View ORCID ProfileGlenn Patriquin, Jason J. LeBlanc, Holly A. Gillis, Gregory R. McCracken, Janice J. Pettipas, Todd F. Hatchette
doi: https://doi.org/10.1101/2022.02.13.22270891
Glenn Patriquin
aDivision of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada
bDepartment of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada
Jason J. LeBlanc
aDivision of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada
bDepartment of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada
cDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
dDepartment of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada
Holly A. Gillis
ePublic Health, Nova Scotia Health, Halifax, Nova Scotia, Canada
Gregory R. McCracken
aDivision of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada
Janice J. Pettipas
fNova Scotia Provincial Public Health Laboratory Network (PPHLN), Halifax, Nova Scotia, Canada
Todd F. Hatchette
aDivision of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada
bDepartment of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada
cDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
dDepartment of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada
Data Availability
All data produced in the present work are contained in the manuscript
Posted February 15, 2022.
Combined oropharyngeal/nares and nasopharyngeal swab sampling remain effective for molecular detection of SARS-CoV-2 Omicron variant
Glenn Patriquin, Jason J. LeBlanc, Holly A. Gillis, Gregory R. McCracken, Janice J. Pettipas, Todd F. Hatchette
medRxiv 2022.02.13.22270891; doi: https://doi.org/10.1101/2022.02.13.22270891
Combined oropharyngeal/nares and nasopharyngeal swab sampling remain effective for molecular detection of SARS-CoV-2 Omicron variant
Glenn Patriquin, Jason J. LeBlanc, Holly A. Gillis, Gregory R. McCracken, Janice J. Pettipas, Todd F. Hatchette
medRxiv 2022.02.13.22270891; doi: https://doi.org/10.1101/2022.02.13.22270891
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (236)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4285)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2767)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4063)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1455)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)